Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan

Published:2024-05-02 Issue:1 Volume:23 Page:485-497
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Shinjoh Masayoshi¹^ORCID,Togo Kanae²^ORCID,Hayamizu Tomoyuki³^ORCID,Yonemoto Naohiro²^ORCID,Morii Junko⁴,Perdrizet Johnna⁵^ORCID,Kamei Kazumasa²^ORCID

Affiliation:

1. Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan

2. Health and Value, Pfizer Japan Inc, Tokyo, Japan

3. Vaccine Medical Affairs, Medical Japan, Pfizer Japan Inc, Tokyo, Japan

4. HEOR, Real World Evidence, IQVIA Solutions G.K, Tokyo, Japan

5. Global Value and Evidence, Pfizer Canada, Montreal, QC, Canada

Funder

Pfizer Japan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2024.2345670

Reference80 articles.

1. Centers for Disease Control and Prevention, Hall E, Wodi AP, Hamborsky J, et al., editors. Epidemiology and prevention of vaccine-preventable diseases. 14th ed. Washington, D.C: Public Health Foundation; 2021.

2. Recent trends in pediatric bacterial meningitis in Japan, 2016-2018 - S. agalactiae has been the most common pathogen;Shinjoh M;J Infect Chemother,2020

3. Extended-Spectrum β-Lactamase–Producing Escherichia coli in Neonates and Listeria monocytogenes in Young Children with Bacterial Meningitis in Japan

4. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan

5. Epidemiological information of invasive pneumococcal infection in children and adults. [overview of FY2013~FY2022] 2022. Available from: https://ipd-information.com/?page_id=46

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Health and Economic Impact of Periodic COVID-19 Vaccination with BNT162b2 for Old Adults and High-Risk Patients in an Illustrative Prefecture of Japan: A Budget Impact Analysis;Infectious Diseases and Therapy;2024-09-10